Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Janux Therapeutics Inc (JANX)

Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,017,210
  • Shares Outstanding, K 51,851
  • Annual Sales, $ 8,080 K
  • Annual Income, $ -58,290 K
  • 60-Month Beta 3.86
  • Price/Sales 365.64
  • Price/Cash Flow N/A
  • Price/Book 7.52
Trade JANX with:

Options Overview Details

View History
  • Implied Volatility 108.21% ( -5.77%)
  • Historical Volatility 79.38%
  • IV Percentile 62%
  • IV Rank 48.25%
  • IV High 203.77% on 02/23/24
  • IV Low 19.10% on 09/19/23
  • Put/Call Vol Ratio 2.47
  • Today's Volume 2,651
  • Volume Avg (30-Day) 1,595
  • Put/Call OI Ratio 0.87
  • Today's Open Interest 12,691
  • Open Int (30-Day) 10,228

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.35
  • Number of Estimates 4
  • High Estimate -0.29
  • Low Estimate -0.39
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.63 +80.28%
on 04/05/24
64.79 -3.64%
on 05/02/24
+26.56 (+74.05%)
since 04/02/24
3-Month
7.79 +701.41%
on 02/05/24
64.79 -3.64%
on 05/02/24
+54.11 (+650.36%)
since 02/02/24
52-Week
5.65 +1,004.96%
on 11/10/23
64.79 -3.64%
on 05/02/24
+47.57 (+320.12%)
since 05/02/23

Most Recent Stories

More News
Why Janux Therapeutics Stock Is Crushing It This Week

Janux's silence about a potential acquisition deal could be golden.

JANX : 62.43 (+7.29%)
Technology Stocks Power the Broader Market Higher

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.74%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.65%. Stock indexes...

$SPX : 5,064.20 (+0.91%)
SPY : 505.03 (+0.94%)
$DOWI : 38,225.66 (+0.85%)
DIA : 382.23 (+0.88%)
$IUXX : 17,541.54 (+1.29%)
QQQ : 426.90 (+1.28%)
ZNM24 : 108-095 (-0.06%)
PARA : 13.86 (+13.05%)
AAPL : 173.03 (+2.20%)
TEAM : 183.55 (+6.24%)
NVDA : 858.17 (+3.34%)
AVGO : 1,238.57 (-0.35%)
Stock Indexes Rise in Afternoon Trade

The S&P 500 Index ($SPX ) (SPY ) is up +0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.26%. Stock indexes are higher even as bond...

$SPX : 5,064.20 (+0.91%)
SPY : 505.03 (+0.94%)
$DOWI : 38,225.66 (+0.85%)
DIA : 382.23 (+0.88%)
$IUXX : 17,541.54 (+1.29%)
QQQ : 426.90 (+1.28%)
ZNM24 : 108-095 (-0.06%)
GL : 79.28 (-0.25%)
KMX : 68.04 (+1.23%)
FAST : 68.09 (-0.13%)
GEN : 19.68 (-1.35%)
KVUE : 19.12 (+1.43%)
Stocks Slightly Higher as US Mar PPI Climbs Less Than Expected

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.36%. Stock indexes this morning...

$SPX : 5,064.20 (+0.91%)
SPY : 505.03 (+0.94%)
$DOWI : 38,225.66 (+0.85%)
DIA : 382.23 (+0.88%)
$IUXX : 17,541.54 (+1.29%)
QQQ : 426.90 (+1.28%)
ZNM24 : 108-095 (-0.06%)
TEAM : 183.55 (+6.24%)
STZ : 254.08 (+0.05%)
AZN : 75.80 (-0.80%)
NVDA : 858.17 (+3.34%)
ALPN : 64.60 (unch)
Why Janux Therapeutics Stock Soared as the Market Sagged Today

One of the hotter biotech companies on the scene might be changing owners before long.

JANX : 62.43 (+7.29%)
2 Stocks That Have More Than Tripled This Year: Are They Buys?

Don't jump on the bandwaggon too quickly.

VKTX : 75.76 (-0.88%)
JANX : 62.43 (+7.29%)
After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy?

The biotech tantalized investors with a very promising data update.

AMGN : 278.39 (+0.37%)
JANX : 62.43 (+7.29%)
Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Tops Revenue Estimates

Janux Therapeutics, Inc. (JANX) delivered earnings and revenue surprises of 14.29% and 21.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

JANX : 62.43 (+7.29%)
GRTS : 0.8700 (-0.42%)
Entera Bio Ltd. (ENTX) Reports Q1 Loss, Misses Revenue Estimates

Entera Bio Ltd. (ENTX) delivered earnings and revenue surprises of 33.33% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ENTX : 2.09 (+4.50%)
JANX : 62.43 (+7.29%)
Analysts Estimate Janux Therapeutics, Inc. (JANX) to Report a Decline in Earnings: What to Look Out for

Janux Therapeutics, Inc. (JANX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

JANX : 62.43 (+7.29%)
RETA : 172.36 (+0.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Janux Therapeutics Inc. is a biopharmaceutical company. It involved in developing novel T cell engager immunotherapies. Janux Therapeutics Inc. is based in LA JOLLA, Calif.

See More

Key Turning Points

3rd Resistance Point 74.39
2nd Resistance Point 69.59
1st Resistance Point 66.01
Last Price 62.43
1st Support Level 57.63
2nd Support Level 52.83
3rd Support Level 49.25

See More

52-Week High 64.79
Last Price 62.43
Fibonacci 61.8% 42.20
Fibonacci 50% 35.22
Fibonacci 38.2% 28.24
52-Week Low 5.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar